PubRank

Cornel Fraefel

Author PubWeight™ 36.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Mol Cell Biol 2009 2.06
2 Functional roles of the tegument proteins of herpes simplex virus type 1. Virus Res 2009 1.38
3 Herpes simplex virus 1 envelopment follows two diverse pathways. J Virol 2005 1.37
4 Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo. Mol Ther 2005 1.01
5 Live visualization of herpes simplex virus type 1 compartment dynamics. J Virol 2008 1.00
6 Imaging-guided gene therapy of experimental gliomas. Cancer Res 2007 0.98
7 Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19. J Virol 2002 0.97
8 Update on herpesvirus amplicon vectors. Mol Ther 2004 0.95
9 Live covisualization of competing adeno-associated virus and herpes simplex virus type 1 DNA replication: molecular mechanisms of interaction. J Virol 2007 0.90
10 Definition of herpes simplex virus type 1 helper activities for adeno-associated virus early replication events. PLoS Pathog 2009 0.89
11 HSV-1 amplicon vectors that direct the in situ production of foot-and-mouth disease virus antigens in mammalian cells can be used for genetic immunization. Vaccine 2010 0.88
12 Herpes simplex virus type 1 amplicons and their hybrid virus partners, EBV, AAV, and retrovirus. Curr Gene Ther 2004 0.87
13 Rotavirus viroplasm fusion and perinuclear localization are dynamic processes requiring stabilized microtubules. PLoS One 2012 0.86
14 Targeted integration of functional human ATM cDNA into genome mediated by HSV/AAV hybrid amplicon vector. Mol Ther 2007 0.86
15 Thymic but not splenic CD8⁺ DCs can efficiently cross-prime T cells in the absence of licensing factors. Eur J Immunol 2011 0.85
16 Switching on the lights for gene therapy. PLoS One 2007 0.84
17 Identification of a single amino acid residue which is critical for the interaction between HSV-1 inner tegument proteins pUL36 and pUL37. Virology 2011 0.82
18 Four-dimensional visualization of the simultaneous activity of alternative adeno-associated virus replication origins. J Virol 2005 0.82
19 Chimeric herpes simplex virus/adeno-associated virus amplicon vectors. Curr Gene Ther 2006 0.82
20 Inhibition of herpes simplex virus type 1 replication by adeno-associated virus rep proteins depends on their combined DNA-binding and ATPase/helicase activities. J Virol 2010 0.81
21 HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice. Mol Ther 2012 0.81
22 Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons. J Virol Methods 2005 0.81
23 Multitracer positron emission tomographic imaging of exogenous gene expression mediated by a universal herpes simplex virus 1 amplicon vector. Mol Imaging 2007 0.81
24 Cloning of Bovine herpesvirus type 1 and type 5 as infectious bacterial artifical chromosomes. BMC Res Notes 2009 0.81
25 Adeno-associated virus type 2 modulates the host DNA damage response induced by herpes simplex virus 1 during coinfection. J Virol 2011 0.81
26 Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector. Gene Ther 2007 0.80
27 Identification of host cell proteins which interact with herpes simplex virus type 1 tegument protein pUL37. Biochem Biophys Res Commun 2011 0.80
28 Glycoprotein D of bovine herpesvirus 5 (BoHV-5) confers an extended host range to BoHV-1 but does not contribute to invasion of the brain. J Virol 2010 0.79
29 Herpes simplex virus type 1 amplicon vector-mediated gene transfer to muscle. Hum Gene Ther 2002 0.79
30 HSV-1 amplicon vectors. Methods Enzymol 2002 0.78
31 Herpesviruses: balance in power and powers imbalanced. Vet Microbiol 2002 0.77
32 Gene delivery using helper virus-free HSV-1 amplicon vectors. Curr Protoc Neurosci 2012 0.77
33 HSV-1 amplicon vectors as genetic vaccines. Methods Mol Biol 2014 0.77
34 Viral and Cellular Components of AAV2 Replication Compartments. Open Virol J 2013 0.77
35 One giant genomic leap for gene transfer technology. Mol Ther 2003 0.77
36 Bioluminescence imaging for in vivo monitoring of local recurrence mesothelioma model. Lung Cancer 2011 0.76
37 Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors. Methods Mol Biol 2014 0.76
38 Herpes simplex virus type 1 (HSV-1)-derived recombinant vectors for gene transfer and gene therapy. Methods Mol Biol 2015 0.76
39 Optimizing glioblastoma temozolomide chemotherapy employing lentiviral-based anti-MGMT shRNA technology. Mol Ther 2013 0.76
40 Herpes simplex virus type 1/adeno-associated virus hybrid vectors. Open Virol J 2010 0.75
41 Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors. Cold Spring Harb Protoc 2012 0.75
42 Infectious delivery of alphaherpesvirus bacterial artificial chromosomes. Methods Mol Biol 2015 0.75
43 Herpes simplex virus/adeno-associated virus hybrid vectors for gene transfer to neurons. Preparation and use. Methods Mol Med 2002 0.75
44 Assessment of a cellular vaccination approach consisting of crawling dendritic cells (CDCs) transduced with HSV-1-Deltapac vectors. Immunol Res 2004 0.75
45 Imaging herpes simplex virus type 1 amplicon vector-mediated gene expression in human glioma spheroids. Mol Imaging 2011 0.75
46 Multifluorescence live analysis of herpes simplex virus type-1 replication. Methods Mol Biol 2014 0.75
47 Construction of HSV-1 BACs and their use for packaging of HSV-1-based amplicon vectors. Methods Mol Biol 2004 0.75